MyFinsight
Home
Blog
About
Back
Income Statement
Matinas BioPharma Holdings, Inc. (MTNB)
Matinas BioPharma Holdings, Inc. (MTNB)
source: myfinsight.com
Net loss attributed
to common...
-$1,326K
Net loss
-$1,326K
(74.72%↑ Y/Y)
Gain on lease
termination
$368K
Loss from operations
-$1,555K
(15.35%↑ Y/Y)
(loss)/gain on disposal of
assets, net
-$138K
(-225.45%↓ Y/Y)
Other income/(loss),
net
-$1K
(98.41%↑ Y/Y)
Total costs and
expenses
$1,555K
(-15.35%↓ Y/Y)
General and
administrative
$1,555K
(-15.35%↓ Y/Y)
Back